The most talked about and market moving research calls around Wall Street are now in one place.
Here are today’s research calls that investors need to know, as compiled by The Fly
Top 5 Upgrades: – Deutsche Bank upgraded Humana (HUM) to Buy from Hold with a price target of $441, up from $235. 2026 should be the earnings bottom for Humana and a rebasing year depending on stars results in October, the firm tells investors in a research note. Deutsche also upgraded Centene (CNC) and Elevance Health (ELV) to Buy. – Arete upgraded Etsy (ETSY) to Buy from Neutral with a $76 price target. The company’s gross merchandise sales growth rates are “finally” showing signs of improvement, the firm tells investors in a research note. – Maxim upgraded Gilead (GILD) to Buy from Hold with a $165 price target.
The company’s growth in the base business is expected to reach 5%-6%, exceeding the prior expectation of 4%-5%, and factoring in the growth potential of Yeztugo in PREP, Trodelvy in first-line breast cancer, as well as continued dominance in HIV treatment, Maxim believes that a premium to peers is justified. – Oppenheimer upgraded Rubrik (RBRK) to Outperform from Perform with an $85 price target, citing strong checks from value-added resellers. The firm believes Rubrik is benefiting from a sharp recovery in backup and recovery/cyber-resilience sector demand. – Jefferies upgraded C.H. Robinson (CHRW) to Buy from Hold with a price target of $200, up from $195.